A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

This study is enrolling participants by invitation only.

Study NCT01369355 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: June 7, 2011 Last Updated: May 10, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is enrolling participants by invitation only.
Estimated Study Completion Date:	September 2018
Estimated Primary Completion Date:	May 2015 (Final data collection date for primary outcome measure)